Assessment of COVID-19 vaccine effectiveness among healthcare workers
- Funded by Estonian Research Council
- Total publications:0 publications
Grant number: VMVPT23512
Grant search
Key facts
Disease
COVID-19Start & end year
20232024Known Financial Commitments (USD)
$246,941.66Funder
Estonian Research CouncilPrincipal Investigator
Uusküla AnneliResearch Location
EstoniaLead Research Institution
University of TartuResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Characterisation of vaccine-induced immunity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Other
Occupations of Interest
Unspecified
Abstract
Estonia is one of the countries participating in a prospective multi-country cohort study of hospital-based healthcare workers (HCW) to evaluate the effectiveness of COVID-19 vaccines in preventing laboratory-confirmed SARS-CoV-2 infection. The combination of data from multiple sites aims at providing sufficient statistical power to meet both the overarching primary objective and a range of more specific secondary objectives. This protocol has been adapted to the rapid vaccine roll-out for COVID-19 in many countries and accommodates the establishment of HCW cohorts subsequent to the implementation of vaccination programmes. All HCWs eligible to be vaccinated with COVID-19 vaccine can be enrolled in the study, including those who have already been vaccinated with a primary COVID-19 vaccination course, those that have received booster dose(s), those who intend or do not intend to be vaccinated and those who are not sure. At enrolment, study participants complete a baseline enrolment survey about demographics, clinical comorbidities, and work- and community-related behaviours related to infection risk. In addition, a serology samples and a respiratory specimens will be collected from participants.